NCT01122875 2016-11-02A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple MyelomaGenentech, Inc.Phase 1 Completed14 enrolled
NCT01363024 2016-11-02Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid TumorsGenentech, Inc.Phase 1 Completed24 enrolled